Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00066768
Status:
COMPLETED
Last Update Posted:
2013-06-04
First Post:
2003-08-06
Brief Title:
Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Non-small Cell Lung Cancer |
| Recurrent Non-small Cell Lung Cancer |
| Stage IIIB Non-small Cell Lung Cancer |
Keywords: